See Emily J, Neto Ary Serpa, Habeeb Zahraa, Bellomo Rinaldo, Wald Ron, Bagshaw Sean M
Departments of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia.
Department of Nephrology, Royal Melbourne Hospital, Melbourne, Australia.
Kidney360. 2025 Jul 1. doi: 10.34067/KID.0000000850.
The purpose of this study is to evaluate whether sex modifies the initiation, prescription, or outcome of KRT, or the relationship between KRT initiation strategy and patient outcomes.
We performed a secondary analysis of STARRT-AKI, a multinational randomized controlled trial comparing accelerated-initiation and standard-initiation of RRT in critically ill adults with acute kidney injury. The primary outcome was all-cause mortality at 90 days. Secondary and tertiary outcomes included renal recovery, mortality in the intensive care unit (ICU) or hospital, and resource utilization. We used logistic and linear regression analyses and interaction testing to explore the effect of KRT initiation strategy on outcomes according to sex.
A total of 2,926 participants from STARRT-AKI were included in this secondary analysis, of whom 937 were female (32%). Females had a lower pre-morbid serum creatinine level and were more likely to be admitted with a medical diagnosis, especially sepsis, compared to males. KRT was initiated with equal frequency in males and females, although females received a higher KRT dose and ultrafiltration intensity. There was no difference in 90-day mortality between sexes, even after covariate adjustment, nor in the number of days alive and free of ventilation, ICU, or hospital. Sex did not modify the association between KRT initiation strategy and survival, KRT dependence, or resource utilization.
In this secondary analysis of the STARRT-AKI trial, KRT initiation and outcome did not differ by sex. An accelerated strategy of KRT initiation did not confer better outcomes to either females or males.
本研究的目的是评估性别是否会改变肾脏替代治疗(KRT)的起始、处方或结果,或者KRT起始策略与患者预后之间的关系。
我们对STARRT-AKI进行了二次分析,这是一项多国随机对照试验,比较了急性肾损伤的危重症成年患者接受肾脏替代治疗的加速起始方案和标准起始方案。主要结局是90天的全因死亡率。次要和三级结局包括肾功能恢复、重症监护病房(ICU)或医院内的死亡率以及资源利用情况。我们使用逻辑回归和线性回归分析以及交互作用检验来探讨KRT起始策略根据性别对预后的影响。
本二次分析纳入了来自STARRT-AKI的2926名参与者,其中937名是女性(32%)。与男性相比,女性病前血清肌酐水平较低,因内科诊断入院的可能性更大,尤其是脓毒症。男性和女性开始KRT的频率相同,尽管女性接受的KRT剂量和超滤强度更高。即使在进行协变量调整后,两性之间的90天死亡率也没有差异,在存活且无需通气、入住ICU或住院的天数方面也没有差异。性别并未改变KRT起始策略与生存、KRT依赖或资源利用之间的关联。
在对STARRT-AKI试验的本次二次分析中,KRT的起始和结局在性别上没有差异。KRT起始的加速策略对女性或男性均未带来更好的预后。